Market Cap
3963625216.00
AMRX
Amneal Pharmaceuticals, Inc.
Exchange: nyse
Multiples
- P/E: -21.49
- P/BV: -28.41
- P/TBV: -6.85
Description:
AMRX is the ticker symbol for Amarin Corporation Plc (AMRN), but it seems there might be a mix-up as AMRX actually refers to Athersys, Inc., a biotechnology company listed on the NYSE. Athersys focuses on the development of novel therapies intended to improve quality of life in patients with unmet medical needs. The company's primary focus lies in the advancement of MultiStem®, a patented stem cell therapy platform designed to treat inflammatory and immune-mediated diseases, as well as neurological conditions.
Data:
Yields:
Earnings Yield
0.220752168288
Return on Capital
0.211444467547
CAGR (net income)
0%
CAGR Length
0
Dividend Rate
